Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 1/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | HTT | P42858 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | LTA4H | P09960 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | ANPEP | P15144 | 1/20 | 0.40 |
| ▸ | LAP3 | P28838 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14880660 | 0.84 | SRC (0.58) | SRCL3MBTL1TDP1KDM4EMEN1 | |
| SCHEMBL23348834 | 0.84 | SRC (0.44) | SRCL3MBTL1TDP1KDM4EMEN1 | |
| SCHEMBL5019770 | 0.82 | SRC (0.56) | SRCL3MBTL1TDP1KDM4EMEN1 | |
| Triphenyl Phosphate SCHEMBL18116 | 0.78 | SRC (0.64) | SRCL3MBTL1TDP1KDM4EMEN1 | |
| SCHEMBL28563480 | 0.78 | SRC (0.64) | SRCL3MBTL1TDP1KDM4EMEN1 | |
| Triphenyl Phosphate SCHEMBL28557783 | 0.78 | SRC (0.64) | SRCL3MBTL1TDP1KDM4EMEN1 | |
| Triphenyl Phosphate SCHEMBL483692 | 0.78 | SRC (0.64) | SRCL3MBTL1TDP1KDM4EMEN1 | |
| Triphenyl Phosphate SCHEMBL28761613 | 0.78 | SRC (0.64) | SRCL3MBTL1TDP1KDM4EMEN1 | |
| Triphenyl Phosphate SCHEMBL11314242 | 0.77 | CYP3A4 (0.56) | SRCL3MBTL1TDP1KDM4EMEN1 | |
| Triphenyl Phosphate SCHEMBL1924512 | 0.76 | SRC (0.61) | SRCL3MBTL1TDP1KDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2768837-B1 | NOVEL TETRAOXASPIRO[5.5]UNDECANE BASED PHOSPHATE COMPOUNDS AND THEIR USE AS FLAME RETARDANTS | PERSTORP AB (SE) | 2016-12-07 | — | — | EP | claimed |
| EP-2768837-A1 | NOVEL TETRAOXASPIRO[5.5]UNDECANE BASED PHOSPHATE COMPOUNDS AND THEIR USE AS FLAME RETARDANTS | PERSTORP AB (SE) | 2014-08-27 | — | — | EP | claimed |
| WO-2013058690-A1 | NOVEL TETRAOXASPIRO[5.5]UNDECANE BASED PHOSPHATE COMPOUNDS AND THEIR USE AS FLAME RETARDANTS | PERSTORP AB (SE) | 2013-04-25 | — | — | WO | claimed |
| EP-0998518-B1 | PROCESS FOR THE PREPARATION OF POLYETHER PHOSPHATES | AMERSHAM HEALTH AS (NO) | 2003-12-10 | — | — | EP | claimed |
| US-6500917-B1 | REACTING SUCH AS POLYETHYLENE GLYCOL WITH A DIARYL- OR DIARALKYL- HALOPHOSPHATE AND REDUCTIVELY CLEAVING ARYL GROUPS; PHOSPHATE MODIFICATION WITH LOW IMPURITIES | AMERSHAM HEALTH AS (NO) | 2002-12-31 | — | — | US | claimed |
| EP-0998518-A1 | PROCESS FOR THE PREPARATION OF POLYETHER PHOSPHATES | NYCOMED IMAGING AS (NO) | 2000-05-10 | — | — | EP | claimed |
| WO-1999005200-A1 | PROCESS FOR THE PREPARATION OF POLYETHER PHOSPHATES | NYCOMED IMAGING AS (NO) | 1999-02-04 | — | — | WO | claimed |
| WO-2024016107-A1 | EFFICIENT PHOSPHORUS-CONTAINING REACTIVE FLAME RETARDANT HAVING IMPROVED STRENGTH AND TOUGHNESS AND PREPARATION METHOD THEREFOR, AND FLAME-RETARDANT THERMOSETTING RESIN | 重庆交通大学 | 2024-01-25 | — | — | WO | disclosed |
| US-20230295198-A1 | VANILLIN-DERIVED FLAME RETARDANT MONOMERS, RESINS, PREPOLYMERS, AND POLYMERS | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2023-09-21 | — | — | US | disclosed |
| WO-2021258199-A1 | VANILLIN-DERIVED FLAME RETARDANT MONOMERS, RESINS, PREPOLYMERS, AND POLYMERS | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2021-12-30 | — | — | WO | disclosed |
| US-20210079036-A1 | COMPOSITIONS AND METHODS FOR CHEMICAL SYNTHESIS | GAP PEPTIDES LLC (US) | 2021-03-18 | — | — | US | disclosed |
| EP-2574614-B1 | Flame-retardant polymer foams with halogen-free flame-retardant agents containing phosphorous on a sugar basis | BASF SE (DE) | 2019-05-01 | — | — | EP | disclosed |
| EP-2788487-B1 | OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA | SAREPTA THERAPEUTICS INC (US) | 2018-04-04 | — | — | EP | disclosed |
| EP-2768837-B1 | NOVEL TETRAOXASPIRO[5.5]UNDECANE BASED PHOSPHATE COMPOUNDS AND THEIR USE AS FLAME RETARDANTS | PERSTORP AB (SE) | 2016-12-07 | — | — | EP | disclosed |
| EP-2768837-A1 | NOVEL TETRAOXASPIRO[5.5]UNDECANE BASED PHOSPHATE COMPOUNDS AND THEIR USE AS FLAME RETARDANTS | PERSTORP AB (SE) | 2014-08-27 | — | — | EP | disclosed |
| WO-2013058690-A1 | NOVEL TETRAOXASPIRO[5.5]UNDECANE BASED PHOSPHATE COMPOUNDS AND THEIR USE AS FLAME RETARDANTS | PERSTORP AB (SE) | 2013-04-25 | — | — | WO | disclosed |
| EP-0998518-B1 | PROCESS FOR THE PREPARATION OF POLYETHER PHOSPHATES | AMERSHAM HEALTH AS (NO) | 2003-12-10 | — | — | EP | disclosed |
| US-6500917-B1 | REACTING SUCH AS POLYETHYLENE GLYCOL WITH A DIARYL- OR DIARALKYL- HALOPHOSPHATE AND REDUCTIVELY CLEAVING ARYL GROUPS; PHOSPHATE MODIFICATION WITH LOW IMPURITIES | AMERSHAM HEALTH AS (NO) | 2002-12-31 | — | — | US | disclosed |
| EP-0998518-A1 | PROCESS FOR THE PREPARATION OF POLYETHER PHOSPHATES | NYCOMED IMAGING AS (NO) | 2000-05-10 | — | — | EP | disclosed |
| WO-1999005200-A1 | PROCESS FOR THE PREPARATION OF POLYETHER PHOSPHATES | NYCOMED IMAGING AS (NO) | 1999-02-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230295198-A1 | VANILLIN-DERIVED FLAME RETARDANT MONOMERS, RESINS, PREPOLYMERS, AND POLYMERS | PNN, PFAS, POLN | SRC 3464/4885L3MBTL1 3978/4885TDP1 1462/4885 |
| US-20210079036-A1 | COMPOSITIONS AND METHODS FOR CHEMICAL SYNTHESIS | NGLY1, DNPEP, HM13 | SRC 1989/4885L3MBTL1 2785/4885TDP1 3221/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.